SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-052930
Filing Date
2023-10-11
Accepted
2023-10-11 17:00:11
Documents
1
Period of Report
2023-09-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5307
  Complete submission text file 0000950170-23-052930.txt   6611
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Issuer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Bernard Thierry (Reporting) CIK: 0001815490 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36571 | Film No.: 231321227